These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11511808)

  • 1. Glycosylations versus conformational preferences of cancer associated mucin core.
    Schuman J; Qiu D; Koganty RR; Longenecker BM; Campbell AP
    Glycoconj J; 2000 Dec; 17(12):835-48. PubMed ID: 11511808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An efficient approach for the characterization of mucin-type glycopeptides: the effect of O-glycosylation on the conformation of synthetic mucin peptides.
    Hashimoto R; Fujitani N; Takegawa Y; Kurogochi M; Matsushita T; Naruchi K; Ohyabu N; Hinou H; Gao XD; Manri N; Satake H; Kaneko A; Sakamoto T; Nishimura S
    Chemistry; 2011 Feb; 17(8):2393-404. PubMed ID: 21264968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probing the conformational and dynamical effects of O-glycosylation within the immunodominant region of a MUC1 peptide tumor antigen.
    Schuman J; Campbell AP; Koganty RR; Longenecker BM
    J Pept Res; 2003 Mar; 61(3):91-108. PubMed ID: 12558945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR analysis of human salivary mucin (MUC7) derived O-linked model glycopeptides: comparison of structural features and carbohydrate-peptide interactions.
    Naganagowda GA; Gururaja TL; Satyanarayana J; Levine MJ
    J Pept Res; 1999 Oct; 54(4):290-310. PubMed ID: 10532235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells.
    Ragupathi G; Howard L; Cappello S; Koganty RR; Qiu D; Longenecker BM; Reddish MA; Lloyd KO; Livingston PO
    Cancer Immunol Immunother; 1999 Apr; 48(1):1-8. PubMed ID: 10235483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of the IgG response in mice and human breast cancer patients following immunization against synthetic sialyl-Tn, an epitope with possible functional significance in metastasis.
    Longenecker BM; Reddish M; Koganty R; MacLean GD
    Adv Exp Med Biol; 1994; 353():105-24. PubMed ID: 7527178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of mucins with the Tn or Sialyl Tn cancer antigens including MUC1 are due to GalNAc-GalNAc interactions.
    Haugstad KE; Hadjialirezaei S; Stokke BT; Brewer CF; Gerken TA; Burchell J; Picco G; Sletmoen M
    Glycobiology; 2016 Dec; 26(12):1338-1350. PubMed ID: 27282157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverse glycosylation of MUC1 and MUC2: potential significance in tumor immunity.
    Irimura T; Denda K; Iida Si; Takeuchi H; Kato K
    J Biochem; 1999 Dec; 126(6):975-85. PubMed ID: 10578046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of the site-specific oligosaccharide distribution of the O-glycans attached to the porcine submaxillary mucin tandem repeat. Further evidence for the modulation of O-glycans side chain structures by peptide sequence.
    Gerken TA; Gilmore M; Zhang J
    J Biol Chem; 2002 Mar; 277(10):7736-51. PubMed ID: 11777921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding studies of alpha-GalNAc-specific lectins to the alpha-GalNAc (Tn-antigen) form of porcine submaxillary mucin and its smaller fragments.
    Dam TK; Gerken TA; Cavada BS; Nascimento KS; Moura TR; Brewer CF
    J Biol Chem; 2007 Sep; 282(38):28256-63. PubMed ID: 17652089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Recognition of GalNAc in Mucin-Type O-Glycosylation.
    Sanz-Martinez I; Pereira S; Merino P; Corzana F; Hurtado-Guerrero R
    Acc Chem Res; 2023 Mar; 56(5):548-560. PubMed ID: 36815693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific core 1 O-glycosylation pattern of the porcine submaxillary gland mucin tandem repeat. Evidence for the modulation of glycan length by peptide sequence.
    Gerken TA; Owens CL; Pasumarthy M
    J Biol Chem; 1998 Oct; 273(41):26580-8. PubMed ID: 9756896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses of mice and human breast cancer patients following immunization with synthetic sialyl-Tn conjugated to KLH plus detox adjuvant.
    Longenecker BM; Reddish M; Koganty R; MacLean GD
    Ann N Y Acad Sci; 1993 Aug; 690():276-91. PubMed ID: 7690215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure and dynamics of mucin-like glycopeptides. Examination of peptide chain expansion and peptide-carbohydrate interactions by stochastic dynamics simulations.
    Butenhof KJ; Gerken TA
    Biochemistry; 1993 Mar; 32(10):2650-63. PubMed ID: 8448122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic modeling confirms the biosynthesis of mucin core 1 (beta-Gal(1-3) alpha-GalNAc-O-Ser/Thr) O-glycan structures are modulated by neighboring glycosylation effects.
    Gerken TA
    Biochemistry; 2004 Apr; 43(14):4137-42. PubMed ID: 15065856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure/activity studies of the anti-MUC1 monoclonal antibody C595 and synthetic MUC1 mucin-core-related peptides and glycopeptides.
    Spencer DI; Missailidis S; Denton G; Murray A; Brady K; Matteis CI; Searle MS; Tendler SJ; Price MR
    Biospectroscopy; 1999; 5(2):79-91. PubMed ID: 10217327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The nature and sequence of the amino acid aglycone strongly modulates the conformation and dynamics effects of Tn antigen's clusters.
    Corzana F; Busto JH; García de Luis M; Jiménez-Barbero J; Avenoza A; Peregrina JM
    Chemistry; 2009; 15(15):3863-74. PubMed ID: 19229941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpected tolerance of glycosylation by UDP-GalNAc:polypeptide alpha-N-acetylgalactosaminyltransferase revealed by electron capture dissociation mass spectrometry: carbohydrate as potential protective groups.
    Yoshimura Y; Matsushita T; Fujitani N; Takegawa Y; Fujihira H; Naruchi K; Gao XD; Manri N; Sakamoto T; Kato K; Hinou H; Nishimura S
    Biochemistry; 2010 Jul; 49(28):5929-41. PubMed ID: 20540529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferred conformations and dynamics of five core structures of mucin type O-glycans determined by NMR spectroscopy and force field calculations.
    Pollex-Krüger A; Meyer B; Stuike-Prill R; Sinnwell V; Matta KL; Brockhausen I
    Glycoconj J; 1993 Oct; 10(5):365-80. PubMed ID: 8298304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deciphering the Non-Equivalence of Serine and Threonine O-Glycosylation Points: Implications for Molecular Recognition of the Tn Antigen by an anti-MUC1 Antibody.
    Martínez-Sáez N; Castro-López J; Valero-González J; Madariaga D; Compañón I; Somovilla VJ; Salvadó M; Asensio JL; Jiménez-Barbero J; Avenoza A; Busto JH; Bernardes GJ; Peregrina JM; Hurtado-Guerrero R; Corzana F
    Angew Chem Int Ed Engl; 2015 Aug; 54(34):9830-4. PubMed ID: 26118689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.